Moderna, Inc.
(NASDAQ : MRNA)

( )
MRNA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -5.23%207.410.0%$1713.99m
BIIBBiogen, Inc. 2.40%406.141.7%$1308.00m
SNSSSunesis Pharmaceuticals, Inc. 9.01%12.950.7%$905.25m
NVAXNovavax, Inc. -0.94%207.7179.8%$703.35m
AMGNAmgen, Inc. -0.65%241.191.3%$607.30m
BNTXBioNTech SE -7.53%220.580.0%$521.84m
GILDGilead Sciences, Inc. 0.13%68.151.0%$461.62m
VRTXVertex Pharmaceuticals, Inc. 0.92%194.801.9%$449.28m
ILMNIllumina, Inc. -0.23%452.143.5%$372.79m
REGNRegeneron Pharmaceuticals, Inc. 0.61%528.752.7%$364.34m
ALXNAlexion Pharmaceuticals, Inc. 0.00%181.652.0%$341.36m
OCGNOcugen, Inc. -3.31%6.130.0%$262.85m
EXASEXACT Sciences Corp. 2.56%125.0118.1%$192.21m
BNGOBionano Genomics, Inc. 3.17%7.820.0%$186.15m
ONTXOnconova Therapeutics, Inc. 6.93%7.561.8%$181.22m

Company Profile

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.